## ## |Trustees/Directors|Trustees/Directors||Prof. K H Nicolaides|| |---|---|---|---|---| ||||Mr Jonathan
Hyett|| ||||Dr. Ranjit S.Akolekar|| ||||Mr. Paul Jacobs|| ||||Dr. Marietta Charakida|| ||||Dr. Argyro Syngelaki|| |Secretary|||Dr. Ranjit S.Akolekar|| |Company|Number||02922302|| |Registered|Office||137Harley Street|| ||||London W1G 6BG|| |Auditors|||AGK Partners|| ||||Chartered
Accountants|& Statutory Auditors| ||||1 Kings Avenue|| ||||London
N21 3NA|| |Accountants|||loannou
8 Co.,|| ||||Chartered
Accountants|| ||||767 -769 High Road|| ||||North Finchley|| ||||London N12 8JY|| |Registered|Charity|Number|1037116|| ## |||||||||Page| |---|---|---|---|---|---|---|---|---| |Trustees'IDirectors'
Report||||||||1 to 4| |Independent|Auditors'|Report||||||5to 8| |Statement of Consolidated|||Income and Expenditure|||and Retained|Earnings|| |Consolidated|Statement|of|Financial||Position|||10| |Company
Statement of||Financial||Position||||| |Consolidated|Statement|of|Cash|Flows||||12| |Consolidated|Statement|of|Financial||Activities|||13to 14| |Accounting|Policies|||||||15to 17| |Notes to the|Accounts|||||||18to 26| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ||||||Notes|2023|2022| |---|---|---|---|---|---|---|---| |||||||'Z|F| |Income|||||||| |Income from charitable
activities||||||1,297,779|179,521| |Rental income||||||330,463|277,194| |Special Services to Hospitals||||||4,760,569|4,600,831| |Net Trading
Surplus
from Non-Charitable|||trading|activities|||| |Income
613,811,438 (2022 -
Expenses
F11,124,420 ( 2022 -||f12,723,232 )
E9,944,299 )|||18 10|2,687,018|2,778,933| |Total Income||||||9,075,829|7,836,479| |Administrative
expenses||||||(2,347,457)|(1,670,023)| |Grants and Donations||||||(3,337,311)|(3,507,572)| |Operating
Surplus
Interest receivable||||||3,391,061
141,505|2,658,884
5,904| |Surplus/(Deficit)
on Ordinary|activities before|||taxation||3,532,566|2,664,788| |Tax on Profit on Ordinary
Activities||||||(134,060)|(129,664)| |Surplus/(Deficit)
on Ordinary|activities after taxation|||||3,398,506|2,535,124| |Total comprehensive
income|for the||year|||3,398,506|2,535,124| |Accumulated
surplus
B/Forward||||||16,010,958|13,475,834| |Accumulated
surplus
C/Forward||||||19,409,464|16,010,958| ## |||||Notes|2023|2022| |---|---|---|---|---|---|---| |Fixed Assets||||||| |Intangible
assets||||9|7,422,011|7,952,155| |Tangible assets||||8a|5,472,907|3,172,728| ||||||12,894,918|11,124,883| |Current Assets||||||| |Debtors|||||2,109,311|1,321,383| |Cash at bank and|in hand||||8,282,267|10,777,738| ||||||10,391,578|12,099,121| |Creditors: Amounts||Falling|Due|||| |Within One Year||||12|(3,877,032)|(7,213,046)| |Net Current Assets|||||6,514,546|4,886,075| ||||||19,409,464|16,010,958| |Creditors: Amounts||Falling|Due|||| |After more than|One|Year||13||| |Total Assets Less Current|||Liabilities||19,409,464|16,010,958| |Capital and Reserves||||||| |Unrestricted
income fund||||15|19,409,464|16,010,958| |Total Funds||||15|19,409,464|16,010,958| ## ## ||||||Notes|2023|2022| |---|---|---|---|---|---|---|---| |Fixed Assets|||||||| |Tangible assets|||||8b|5,028,288|2,623,592| |Investments|||||10|1,802|1,802| |||||||5,030,090|2,625,394| |Current Assets|||||||| |Debtors||||||8,755,864|8,698,887| |Cash at bank|and|in hand||||7,875,347|10,003,941| |||||||16,631,211|18,702,828| |Creditors: Amounts|||Falling|Due|||| |Within One|Year||||12|(2,738,150)|(5,821,954)| |Net Current|Assets|||||13,893,061|12,880,874| |||||||18,923,151|15,506,268| |Total Assets|Less Current|||Liabilities||18,923,151|15,506,268| |Capital and|Reserves||||||| |Unrestricted|income fund||||15|18,923,151|15,506,268| |Total Funds|||||15|18,923,151|15,506,268| ## ||||Notes|31-Mar-23|31-Mar-22| |---|---|---|---|---|---| |Cash flows from operating|activities||||| |Profit for the financial year||||3,532,566|2,664,788| |Adjustments
for:
Depreciation
oftangible assets||||382,931|441,173| |Amortisation
of goodwill||||530,144|530,144| |Interest receivable
and similar income||||141,505|5,904| |Interest payable
& similar charges
Accrued expenses/(income)||||(3,103,801)|3,970,778| |Changes
in:|||||| |Trade and other debtors||||(787,928)|2,195,006| |Trade and other creditors||||(366,273)|(5,827,636)| |Cash generated
from operations||||329,144|3,980,157| |Interest paid|||||| |Interest received||||(141,505)|(5,904)| |Net cash from operating
activities|||16|187,639|3,974,253| |Cash flows from investing|activities||||| |Purchase
oftangible assets|||8a|(2,683,110)|| |Net cash used
in investing|activities|||(2,683,110)|| |Net increase/(decrease)
in|cash and cash|equivalents||(2,495,471)|3,974,253| |Cash and cash equivalents|at beginning|ofyear||10,777,738|6,803,485| |Cash and cash equivalents|at end ofyear||18|8,282,267|10,777,738| ## ||||Unrestricted|Total|Total| |---|---|---|---|---|---| |||Notes|Funds|2023|2022| |Incoming
Resources|||||| |Donations
and fund raising|||58,490|58,490|26,620| |Rental Income|||330,463|330,463|277,194| |EU Grant|||||| |Special Services to Hospitals|||4,760,569|4,760,569|4,600,831| |Other income|||1,239,289|1,239,289|152,901| |||2|6,388,811|6,388,811|5,057,546| |Interest receivable|||141,505|141,505|5,904| ||||6,530,316|6,530,316|5,063,450| |Net trading
Surplus|||||| |from trading
subsidiaries||10|2,687,018|2,687,018|2,778,933| |Total Incoming
resources|||9,217,334|9,217,334|7,842,383| ||||Unrestricted|Total|Total| ||||Funds|2023|2022| |Resources Expended|||||| |Direct Charitable
Expenditure|||||| |Grants for research|||2,836,066|2,836,066|3,007,356| |Donations|||501,245|501,245|500,216| |Educational
activities|||885,220|885,220|221,159| ||||4,222,531|4,222,531|3,728,731| |Other Expenditure|||||| |Depreciation|||278,414|278,414|335,189| |Adrnin
and Costs ofGrant|Making||1,183,823|1,183,823|1,113,675| |Financial costs|||||| |Total Expenditure|||5,684,768|5,684,768|5,177,595| |Surplus/(deficit)
for the year before tax|||3,532,566|3,532,566|2,664,788| |Tax on Profit of ordinary|activities||(134,060)|(134,060)|129,664)| |Surplus/(deficit)
for the year after tax|||3,398,506|3,398,506|2,535,124| ## ## |||||Unrestricted|Total|Total| |---|---|---|---|---|---|---| ||||Notes|Funds|2023|2022| |Reconciliation|of|Movement||||| |of Funds||||||| |Opening
funds|||15|16,010,958|16,010,958|13,475,834| |Surplus of incoming||||||| |resources for|the|year|15|3,398,506|3,398,506|2,535,124| |Closing funds|||15|19,409,464|19,409,464|16,010,958| |Non-controlling|interests|||||| |||||19,409,464|19,409,464|16,010,958| |Funds balance|at 31 March 2023|||||| |Represented
by:—||||||| |Intangible
fixed assets|||9|7,422,011|7,422,011|7,952,155| |Tangible
fixed assets
Debtors less creditors|||8a|5,472,907
(1,767,721)|5,472,907
(1,767,721)|3,172,728
(5,891,663)| |Cash at bank and||in hand||8,282,267|8,282,267|10,777,738| |Provision||||||| |||||19,409,464|19,409,464|16,010,958| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |Operating
Surplus/(deficit)|Operating
Surplus/(deficit)|||| |---|---|---|---|---| |Operating
surplus/(deficit)|is|stated after charging:|2023|2022| ||||F|E| |Rent Payable —premises|||905,520|903,648| |Depreciation
ofowned assets|||382,931|441,173| |Amortisation
of intangible|assets||530,144|530,144| |Auditors
remuneration|||17,764|16,020| |Interest Payable and Similar||Charges|2023|2022| ||||F|g| |Bank overdraft
and other interest||||| |Staff Costs|||2023|2022| ||||E|E| |Salaries and wages
Social security costs
Other pension costs|||3,836,614
409,128
114,233|3,456,564
337,056
104,808| ||||4,359,975|3,898,428| ||||2023|2022| |Average
number
of staff during
Average
number
ofstaff during||the year - Group
the year - Company|133
59|106
36| |No member of staff of the|Charity received a salary greater than F60,000 per annum.|||| ## ## |of its objects for the public benefit
in early f|etal diagnosis
and therapy.|| |---|---|---| ||2023|2022| |||F| |Individuals|2,836,066|3,007,356| ## |During the year the Charity mad|e the following
donations.||| |---|---|---|---| |||2023|2022| ||||E| |King's College NHS Foundation|Trust|500,000|500,000| |Windsor Walk||1,029|| |Other Donations||216
501,245|216
500,216| ## |Tangible Fixed Assets|- Group||||| |---|---|---|---|---|---| ||Freehold|Leasehold|Plant and|Furniture|| ||Property|Property|Machinery|8 Equip|Total| |Cost|||||| |At 1 April 2022
Additions|2,683,110|1,693,398|4,125,888|2,387,817|8,207,103
2,683,110| |At 31 March 2023|2,683,110|1,693,398|4,125,888|2,387,817|10,890,213| |Depreciation
At 1 April 2022
Charge for the year||204,049
52,575|3,133,964
198,385|1,696,362
131,971|5,034,375
382,931| |At 31 March 2023||256,624|3,332,349|1,828,333|5,417,306| |Net Book Value|||||| |At 31 March 2023|2,683,110|1,436,774|793,539|559,484|5,472,907| |Net Book Value|||||| |At 31 March 2022||1,489,349|991,924|691,455|3,172,728| ## |Tangible
Fixed Assets|- Company||||| |---|---|---|---|---|---| ||Freehold|Leasehold|Plant and|Furniture|| ||Property|Property|Machinery
f|& Equip
f|Total
f| |Cost|||||| |At 1 April 2022
Additions|2,683,110|1,680,760|3,860,724|814,825|6,356,309
2,683,110| |At 31 March 2023|2,683,110|1,680,760|3,860,724|814,825|9,039,419| |Depreciation
At 1 April 2022
Charge for the year||192,673
51,313|2,878,588
196,427|661,456
30,674|3,732,717
278,414| |At 31 March 2023||243,986|3,075,015|692,130|4,011,131| |Net Book Value|||||| |At 31 March 2023|2,683,110|1,436,774|785,709|122,695|5,028,288| |Net Book Value|||||| |At 31 March 2022||1,488,087|982,136|153,369|2,623,592| ## ## ## ## ## ## ## |11|Debtors|||||||||| |---|---|---|---|---|---|---|---|---|---|---| |||||||Notes|Group||Company|| ||||||||2023|2022|2023|2022| ||||||||E|F|E|E| |Amounts
due||from|group company||||||7,509,900|7,929,537| |Trade|Debtors||||||1,730,505|940,483|1,040,767|551,760| |Other|Debtors||||||15,825|12,885||| |Prepayments||and|accrued||income||362,981|368,015|205,197|217,590| ||||||||2,109,311|1,321,383|8,755,864|8,698,887| |12|Creditors: Amounts||||Falling Due|Within|One Year|||| |||||||Notes|Group||Company|| ||||||||2023|2022|2023|2022| |||||||||F|E|E| |Amounts
due to group
Trade creditors||||company|||1,254,233|1,545,770|156,094
571,071|73,934
644,035| |Corporation
Tax
Other taxes and social||||security|||132,861
68,610|128,307
31,772|68,610|31,772| |Other|creditors||||||373,000|355,068|10,656|12,205| |Accruals and deferred||||income|||2,048,328|5,152,129|1,931,719|5,060,008| ||||||||3,877,032|7,213,046|2,738,150|5,821,954| |13|Creditors: Amounts||||Falling Due|After More Than One Year||||| ||||||||Group||Company|| ||||||||2023|2022|2023|2022| ||||||||E|||E| |Other|Creditors|||||||||| ||||||||Group||Company|| ||||||||2023|2022|2023|2022| ||||||||E|F|E|E| |Repayable
between|||one and five years|||||||| ## |14|Commitments
under Operatin|Commitments
under Operatin|Commitments
under Operatin|g
Leases|||||||| |---|---|---|---|---|---|---|---|---|---|---|---| ||At 31 March 2023 the group|||has annual|commitments
under|non-cancellable|||operating
leases||as set out| ||below.||||||||||| ||||||Group||||Company||| ||||||Land and buildings||||Land and|buildings|| ||Operating
leases which|expire:|||2023
E||2022||2023
E||2022f| ||Within
1 year
Within 2 to 5 years
After more than 5 years||||150,245
599,400
3,633,863||868,025
1,099,887
6,901,228||542,367
499,500
2,992,640||614,175
500,092
3,117,515| ||||||4,383,508||8,869,140||4,034,507||4,231,782| |15|Reconciliation
of Funds||||||||||| ||||||Group||||Company||| ||||||2023||2022||2023||2022| ||||||F||E||E||| ||Opening
accumulated
funds - Unrestricted||||16,010,958||13,475,834||15,506,268|12,942,493|| ||Surplus
for the year||||3,398,506||2,535,124||3,416,883||2,563,775| ||Unrestricted
Fund||||19,409,464||16,010,958||18,923,151|15,506,268|| ||Share Premium||||||||||| ||Non-controlling
interests
Total Funds||||19,409,464||16,010,958||18,923,151|15,506,268|| ||Closing accumulated
funds -||Unrestricted||19,409,464||16,010,958||18,923,151|15,506,268|| ||Total Funds||||19,409,464||16,010,958||18,923,151|15,506,268|| |16|Reconciliation
ofoperating
profit to||||net cash inflow from||operating|activities|||| ||||||||||2023||2022| ||Operating
profit
Depreciation
Amortisation||||||||3,391,061
382,931
530,144||2,658,884
441,173
530,144| ||(Increase)/Decrease|in debtors|||||||(787,928)||2,195,006| ||Increase/(Decrease)|in creditors|||||||(366,273)|(5,827,636)|| ||Accrued expenses/(Income)||||||||(3,103,801)||3,970,778| ||Interest Payable
and
Interest receivable|similar charges|||||||141,505||5,904| ||Net cash inflow/(outflow)||from operating||activities||||187,639||3,974,253| |17|Analysis ofchanges|in|cash and cash equivalents
during||||the year||||| ||||||||||2023||2022| ||||||||||E||| ||Balance at 1 April 2022
Net cash inflow/(outflow)||||||||10,777,738
~2,495,471)|6,803,485
3,974,253|| ||Balance at 31 March|2023|||||||8,282,267|10,777,738|| |Analy|sis o|fthe ba|lances ofcash and cash|equivalents
as shown
in the|balance sheet|| |---|---|---|---|---|---|---| |||||||Changein| |||||2023|2022|Year| ||||||E|F| |Cash|at Bank|||8,266,587|10,766,843|(2,500,256)| |Cash|in Hand|||15,680|10,895|4,785| |Total|cash|at bank|in hand|8,282,267|10777,738 ,|~(2,495,471| |||||8,282,267|10,777,738|2,495,471| ##